|
LRRC8D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.77635683940025E-15 |
| Normal-vs-Stage2 |
2.20189999999842E-05 |
| Normal-vs-Stage3 |
6.66133814775094E-15 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
4.882300E-02 |
| Stage1-vs-Stage3 |
7.962000E-02 |
| Stage1-vs-Stage4 |
8.11870000000381E-05 |
| Stage2-vs-Stage3 |
5.638900E-03 |
| Stage2-vs-Stage4 |
9.59440000000145E-05 |
| Stage3-vs-Stage4 |
7.272000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22044604925031E-16 |
| Normal-vs-AfricanAmerican |
1.62230000544383E-08 |
| Normal-vs-Asian |
1.80544468264543E-12 |
| Caucasian-vs-AfricanAmerican |
7.251600E-01 |
| Caucasian-vs-Asian |
2.634200E-01 |
| AfricanAmerican-vs-Asian |
7.313600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.00683913931243E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
4.517400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
6.26054763586126E-13 |
| Normal-vs-Age(61-80Yrs) |
1.68776104203516E-12 |
| Normal-vs-Age(81-100Yrs) |
1.002160E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.523400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.212600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.433400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.566400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.569200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.436600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.159100E-04 |
| Classical-VS-Follicular |
5.997100E-04 |
| Classical-VS-Other |
9.832600E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
5.42610000264787E-08 |
| Tall-VS-Other |
3.647000E-01 |
| Tall-VS-Normal |
1.11022302462516E-16 |
| Follicular-VS-Other |
3.242200E-01 |
| Follicular-VS-Normal |
1.08160000000801E-06 |
| Other-VS-Normal |
2.095200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.13640208354582E-11 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
4.75450000037014E-07 |
|
|
